Kristel Van Steen is a scholar working on Genetics, Molecular Biology and Epidemiology.
According to data from OpenAlex, Kristel Van Steen has authored 190 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Genetics, 63 papers in Molecular Biology and 37 papers in Epidemiology. Recurrent topics in Kristel Van Steen's work include Genetic Associations and Epidemiology (49 papers), Inflammatory Bowel Disease (45 papers) and Bioinformatics and Genomic Networks (34 papers). Kristel Van Steen is often cited by papers focused on Genetic Associations and Epidemiology (49 papers), Inflammatory Bowel Disease (45 papers) and Bioinformatics and Genomic Networks (34 papers). Kristel Van Steen collaborates with scholars based in Belgium, United States and Netherlands. Kristel Van Steen's co-authors include Séverine Vermeire, Gert Van Assche, Paul Rutgeerts, Marc Ferrante, Maja Noman, Ingrid Arijs, Fabian Schnitzler, Herma H. Fidder, Ilse Hoffman and Jestinah Mahachie John and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Kristel Van Steen
181 papers
receiving
8.8k citations
Hit Papers
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
2015636 citationsNiels Vande Casteele, Marc Ferrante et al.Gastroenterologyprofile →
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease
2009533 citationsMarc Ferrante, Maja Noman et al.Inflammatory Bowel Diseasesprofile →
Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis
2011457 citationsKristel Van Steen et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Kristel Van Steen
Since
Specialization
Citations
This map shows the geographic impact of Kristel Van Steen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristel Van Steen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristel Van Steen more than expected).
Fields of papers citing papers by Kristel Van Steen
This network shows the impact of papers produced by Kristel Van Steen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristel Van Steen. The network helps show where Kristel Van Steen may publish in the future.
Co-authorship network of co-authors of Kristel Van Steen
This figure shows the co-authorship network connecting the top 25 collaborators of Kristel Van Steen.
A scholar is included among the top collaborators of Kristel Van Steen based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Kristel Van Steen. Kristel Van Steen is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Pineda, Sílvia, Núria Malats, & Kristel Van Steen. (2013). Integration analysis of 'OMICS' data using penalized regression methods : an application to bladder cancer. Human Heredity. 76(2). 100–100.1 indexed citations
John, Jestinah Mahachie, Elena S. Gusareva, François Van Lishout, & Kristel Van Steen. (2012). A robustness study to investigate the performance of parametric and non-parametric tests used in Model-Based Multifactor Dimensionality Reduction Epistasis Detection. BioData Mining.
13.
Steen, Kristel Van. (2011). Travelling the world of gene-gene interactions – invited submission to Briefings in Bioinformatics. Open Repository and Bibliography (University of Liège).2 indexed citations
14.
Gusareva, Elena S., Jeroen R. Huyghe, & Kristel Van Steen. (2011). Genome-wide epistasis screening for asthma associated traits. Open Repository and Bibliography (University of Liège).
15.
Drobne, David, Peter Bossuyt, Christine Breynaert, et al.. (2011). Long term evolution and impact of immunomodulator cotreatment and withdrawal on infliximab on trough levels in 223 patients with Crohn's disease. Open Repository and Bibliography (University of Liège).2 indexed citations
16.
Cleynen, Isabelle, Wouter Van Moerkercke, Niels Vande Casteele, et al.. (2011). Anti-TNF induced skin manifestations in IBD patients: characterization and search for predisposing factors. Open Repository and Bibliography (University of Liège).5 indexed citations
Bottomley, Andrew, Egbert F. Smit, Fabio Efficace, et al.. (2005). Non-small cell lung cancer and health-related quality of life (HRQOL): Is baseline HRQOL of prognostic value for survival?. Open Repository and Bibliography (University of Liège).1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.